Press Release BioInvent Announces Publication of Preclinical Manuscript on BI-1808 and BI-1910 in Cancer Research 18 hours ago
Press Release BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Ovarian Cancer Aug 7
Press Release BioInvent Publication in JECCR: Tailored FcγR Blockade with BI-1206 and BI-1607 Enhances Cancer Antibody Therapies and Overcomes Resistance in Preclinical Models Jul 28